| Christina Hayfron-benjamin, MD | |
|
230 Main St, Agawam, MA 01001-1838 | |
| (413) 789-6800 | |
| (413) 789-5171 |
| Full Name | Christina Hayfron-benjamin |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 30 Years |
| Location | 230 Main St, Agawam, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447350772 | NPI | - | NPPES |
| 110054763A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 80088 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Care | Agawam, MA | Home health agency |
| Baystate Home Health | Springfield, MA | Home health agency |
| Caretenders | Holyoke, MA | Home health agency |
| Elara Caring | Newton, MA | Home health agency |
| Mercy Medical Ctr | Springfield, MA | Hospital |
| Baystate Medical Center | Springfield, MA | Hospital |
| Baystate Noble Hospital | Westfield, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Riverbend Medical Group Inc | 5698064343 | 159 |
News Archive
The November 2012 issue of USAID's "Global Health News" newsletter focuses on tuberculosis (TB).
SureScripts on Tuesday unveiled a Web site that will allow health care workers to access the prescription information of people who live in areas impacted by natural disasters, the AP/Jackson Clarion-Ledger reports.
A study from Lund University in Sweden shows that commonly used chemo toxins impair the eyesight in childhood cancer survivors in a way that indicates an impact on the central nervous system.
Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. today announced results from a Phase IIb/III clinical trial for CINQUIL(TM) (reslizumab) as a treatment for pediatric eosinophilic esophagitis (EoE). The study was designed to evaluate improvement in the co-primary endpoints of changes in esophageal eosinophil levels and clinical symptoms.
rL Solutions, the leading provider of healthcare quality and safety software, announced today that its claims management software, Claims MonitorPro(R) (CMPro) can assist healthcare organizations in meeting the new CMS Section 111 reporting requirements.
› Verified 6 days ago
| Entity Name | Riverbend Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841651197 PECOS PAC ID: 5698064343 Enrollment ID: O20160614001710 |
News Archive
The November 2012 issue of USAID's "Global Health News" newsletter focuses on tuberculosis (TB).
SureScripts on Tuesday unveiled a Web site that will allow health care workers to access the prescription information of people who live in areas impacted by natural disasters, the AP/Jackson Clarion-Ledger reports.
A study from Lund University in Sweden shows that commonly used chemo toxins impair the eyesight in childhood cancer survivors in a way that indicates an impact on the central nervous system.
Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. today announced results from a Phase IIb/III clinical trial for CINQUIL(TM) (reslizumab) as a treatment for pediatric eosinophilic esophagitis (EoE). The study was designed to evaluate improvement in the co-primary endpoints of changes in esophageal eosinophil levels and clinical symptoms.
rL Solutions, the leading provider of healthcare quality and safety software, announced today that its claims management software, Claims MonitorPro(R) (CMPro) can assist healthcare organizations in meeting the new CMS Section 111 reporting requirements.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christina Hayfron-benjamin, MD 230 Main St, Agawam, MA 01001-1838 Ph: (413) 789-6800 | Christina Hayfron-benjamin, MD 230 Main St, Agawam, MA 01001-1838 Ph: (413) 789-6800 |
News Archive
The November 2012 issue of USAID's "Global Health News" newsletter focuses on tuberculosis (TB).
SureScripts on Tuesday unveiled a Web site that will allow health care workers to access the prescription information of people who live in areas impacted by natural disasters, the AP/Jackson Clarion-Ledger reports.
A study from Lund University in Sweden shows that commonly used chemo toxins impair the eyesight in childhood cancer survivors in a way that indicates an impact on the central nervous system.
Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. today announced results from a Phase IIb/III clinical trial for CINQUIL(TM) (reslizumab) as a treatment for pediatric eosinophilic esophagitis (EoE). The study was designed to evaluate improvement in the co-primary endpoints of changes in esophageal eosinophil levels and clinical symptoms.
rL Solutions, the leading provider of healthcare quality and safety software, announced today that its claims management software, Claims MonitorPro(R) (CMPro) can assist healthcare organizations in meeting the new CMS Section 111 reporting requirements.
› Verified 6 days ago
Matthew J. Kane, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 230 Main St, Agawam, MA 01001 Phone: 413-789-6800 Fax: 413-789-8048 | |
Daniel W. Weiswasser, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 230 Main St, Agawam, MA 01001 Phone: 413-789-8010 Fax: 413-789-5171 | |
James Paul Gallagher, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 61 Cooper St, Agawam, MA 01001 Phone: 413-786-8000 Fax: 413-786-2124 | |
Irene N Cody, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 230 Main St, Agawam, MA 01001 Phone: 413-789-6800 Fax: 413-789-5171 |